A major new RCT of Structured Psychological Support finds brief therapy offers no meaningful benefit over usual care for ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
The aim of this study was to evaluate the performance of an artificial intelligence (AI)–based method for automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results